Charles River Labs Intl buy Bank of America Co.
Start price
15.12.25
/
50%
€168.60
Target price
15.12.26
€191.66
Performance (%)
-5.07%
Price
06.02.26
€160.05
Summary
This prediction is currently active. With a performance of -5.07%, the BUY prediction by Bank_of_America_Co_ is trending in the wrong direction. This prediction currently runs until 15.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | -9.882% | -9.882% |
| iShares Core DAX® | 1.085% | -0.846% |
| iShares Nasdaq 100 | -1.665% | -3.306% |
| iShares Nikkei 225® | 3.863% | 6.308% |
| iShares S&P 500 | 0.111% | -1.337% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.
Ratings data for CRL provided by MarketBeat